Literature DB >> 2433163

Substance P and immunoregulation.

J P McGillis, M L Organist, D G Payan.   

Abstract

Peptides released from peripheral nerve endings in mammals, including the tachykinin substance P (SP) and vasoactive intestinal polypeptide (VIP), are potent mediators of smooth muscle and vascular functions. Significant neurophysiological activities of SP and VIP include the transmission of nociceptive and interneuron excitatory signals, respectively. SP has been shown to modulate distinct immediate hypersensitivity responses by stimulating the generation of arachidonic acid-derived mediators from mucosal mast cells but not basophils. Functions of mononuclear and polymorphonuclear leukocytes that characterize the inflammatory response and that are altered by SP include chemotaxis, lysosomal enzyme release, and phagocytic activities. The effects of SP on cell-mediated immunity are largely stimulatory, in that synthesis of DNA, protein, and immunoglobulin by mature T and B lymphocytes, respectively, is significantly enhanced at nanomolar concentrations of the neuropeptide. Functionally relevant receptors for SP on T lymphocytes have been demonstrated by cell sorter and radioligand-binding techniques, and the lymphocyte membrane proteins that comprise the SP receptor are currently being isolated and purified to homogeneity. The characterization of the structure of the SP lymphocyte receptor and identification of the receptor gene will permit detailed analyses of the molecular interactions between the immune and nervous systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433163

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  15 in total

1.  Involvement of tachykinin receptors in sensitisation to cow's milk proteins in guinea pigs.

Authors:  J Gay; J Fioramonti; R Garcia-Villar; X Emonds-Alt; L Bueno
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Distribution of somatostatin-immunoreactive nerve fibres in Peyer's patches.

Authors:  E Fehér; M Fodor; G Burnstock
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

3.  Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.

Authors:  Mark M Manak; Dmitry A Moshkoff; Lequan T Nguyen; John Meshki; Pablo Tebas; Florin Tuluc; Steven D Douglas
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

Review 4.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

5.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

Authors:  P G Kennedy; J Rodgers; F W Jennings; M Murray; S E Leeman; J M Burke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors:  E Haker; E Theodorsson; T Lundeberg
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

8.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

9.  The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P.

Authors:  Ralph A Tripp; Azzeddine Dakhama; Les P Jones; Albert Barskey; Erwin W Gelfand; Larry J Anderson
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophages.

Authors:  Xu Wang; Steven D Douglas; Li Song; Yan-Jian Wang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.